3 Biochemical markers in blood can predict cirrhotic evolution of chronic hepatitis

A study of non-invasive method for liver fibrosis and prediction of hepatocellular carcinoma

Evaluation of endoglin as a non–invasive marker of hepatic fibrosis in chronic hepatitis C patients

Serum hyaluronic acid as a useful marker of liver fibrosis in chronic hepatitis C virus infection

Evaluation of serum fibrogenicmarkers in relation to histopathological findings inpatients with chronic hepatitis C

Determination of serum levels ofmalondialdehyde and ceruloplasmin in HCV patients

Serum laminin and syndecan -1 : Novel biomarkers in predicting liver fibrosis stage in patients with hepatocllular carcinoma

Non-invasive fibrosis markers and transient elastography versus liver biopsy as predictors for end treatment response in chronic HCV patients receiving pegylated interferon and ribavirin

Determination of serum levels ofMalondialdehyde & Ceruloplasmin inHCV patients

Clinical biochemical markers for hepatocellular carcinoma in Egyptian patients